Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival
Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
180542
Cancerfonden
2019
Umea University
2019
Lion's cancer research foundation
2019
Region Västerbotten
MMCI, 00209805
Ministry of health Czech Republic
PubMed
32867395
PubMed Central
PMC7503265
DOI
10.3390/ijms21176220
PII: ijms21176220
Knihovny.cz E-zdroje
- Klíčová slova
- MHC I, SCCOT, TAP1, field cancerization,
- MeSH
- analýza přežití MeSH
- biopsie MeSH
- časná detekce nádoru MeSH
- dospělí MeSH
- down regulace * MeSH
- jazyk chemie patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery genetika MeSH
- nádory jazyka genetika mortalita patologie MeSH
- peptidový transportér TAP1 genetika MeSH
- prognóza MeSH
- regulace genové exprese u nádorů MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- spinocelulární karcinom genetika mortalita patologie MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- nádorové biomarkery MeSH
- peptidový transportér TAP1 MeSH
- TAP1 protein, human MeSH Prohlížeč
Oral cancers are surrounded by epithelium that histologically might seem normal, but genetically has aberrations. In patients with squamous cell carcinoma of the oral tongue (SCCOT), it is therefore important to study not only the tumor but also the clinically tumor-free contralateral tongue tissue that remains in the patient after treatment to map changes of prognostic and/or diagnostic value. The transporter associated with antigen processing (TAP) dimer is a key factor in the process of activating cytotoxic T cells. By downregulating the expression of TAP, tumor cells can escape cytotoxic T cell recognition. Biopsies from tumor and clinically tumor-free contralateral tongue tissue in 21 patients with SCCOT were analyzed together with tongue biopsies from 14 healthy individuals, which served as the control group. Dividing patients into TAP1-high and TAP1-low groups according to the median TAP1 level in tumor-free samples showed that patients with lower TAP1 mRNA levels in tumor-free samples had better overall (p = 0.003) and disease-free survival (p = 0.002). The results showing that TAP1 levels in tumor-free tongue tissue contralateral to the SCCOT correlate with survival is an important contribution to early diagnosis and follow up of SCCOT.
Department of Clinical Sciences ENT Umeå University SE 901 85 Umeå Sweden
Department of Medical Biosciences Umeå University SE 901 85 Umeå Sweden
Institut de Génétique Moléculaire Université Paris 7 Inserm UMR 1162 750 13 Paris France
RECAMO Masaryk Memorial Cancer Institute Zluty kopec 7 656 53 Brno Czech Republic
Zobrazit více v PubMed
Sgaramella N., Gu X., Boldrup L., Coates P.J., Fåhraeus R., Califano L., Tartaro G., Colella G., Spaak L.N., Strom A., et al. Searching for New Targets and Treatments in the Battle Against Squamous Cell Carcinoma of the Head and Neck, with Specific Focus on Tumours of the Tongue. Curr. Top. Med. Chem. 2018;18:214–218. doi: 10.2174/1568026618666180116121624. PubMed DOI
Sano D., Myers J.N. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 2007;26:645–662. doi: 10.1007/s10555-007-9082-y. PubMed DOI
Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6:963–968. doi: 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q. PubMed DOI
Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., Brakenhoff R.H. A genetic explanation of Slaughter’s concept of field cancerization: Evidence and clinical implications. Cancer Res. 2003;63:1727–1730. PubMed
Lochhead P., Chan A.T., Nishihara R., Fuchs C.S., Beck A.H., Giovannucci E., Ogino S. Etiologic field effect: Reappraisal of the field effect concept in cancer predisposition and progression. Mod. Pathol. 2015;28:14–29. doi: 10.1038/modpathol.2014.81. PubMed DOI PMC
Gu X., Boldrup L., Coates P.J., Fahraeus R., Wang L., Wilms T., Norberg-Spaak L., Sgaramella N., Nylander K. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue. J. Pathol. Clin. Res. 2019;5:240–247. doi: 10.1002/cjp2.138. PubMed DOI PMC
Rosenberg J., Huang J. CD8+ T cells and NK cells: Parallel and complementary soldiers of immunotherapy. Curr. Opin. Chem. Eng. 2018;19:9–20. doi: 10.1016/j.coche.2017.11.006. PubMed DOI PMC
Abele R., Tampe R. The ABCs of Immunology: Structure and Function of TAP, the Transporter Associated with Antigen Processing. Physiology. 2004;19:216–224. doi: 10.1152/physiol.00002.2004. PubMed DOI
Ritz U., Seliger B. The Transporter Associated With Antigen Processing (TAP): Structural Integrity, Expression, Function, and Its Clinical Relevance. Mol. Med. 2001;7:149–158. doi: 10.1007/BF03401948. PubMed DOI PMC
Eggensperger S., Tampe R. The transporter associated with antigen processing: A key player in adaptive immunity. Biol. Chem. 2015;396:1059–1072. doi: 10.1515/hsz-2014-0320. PubMed DOI
Lankat-Buttgereit B., Tampe R. The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases. Physiol. Rev. 2002;82:187–204. doi: 10.1152/physrev.00025.2001. PubMed DOI
Bandoh N., Ogino T., Katayama A., Takahara M., Katada A., Hayashi T., Harabuchi Y. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol. Rep. 2010;23:933–939. doi: 10.3892/or_00000717. PubMed DOI
Boldrup L., Gu X., Coates P.J., Norberg-Spaak L., Fåhraeus R., Laurell G., Wilms T., Nylander K. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma. Oncotarget. 2017;8:19389–19402. doi: 10.18632/oncotarget.14288. PubMed DOI PMC
Meissner M., Reichert T.E., Kunkel M., Gooding W., Whiteside T.L., Ferrone S., Seliger B. Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome. Clin. Cancer Res. 2005;11:2552–2560. doi: 10.1158/1078-0432.CCR-04-2146. PubMed DOI
Han W., Pan H., Jiang L., Wei K., Zou D., Zhang Z. A novel approach to rescue immune escape in oral squamous cell carcinoma: Combined use of interferon-γ and LY294002. Oncol. Rep. 2011;25:181–187. PubMed
Wei H., Hongya P., Linlin J., Mujiang A., Kuijie W., Duohong Z., Qingang H., Zhiyuan Z. IFN-γ enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma. Arch. Oral Biol. 2011;56:891–898. doi: 10.1016/j.archoralbio.2011.02.008. PubMed DOI
Tanaka K., Tsuchikawa T., Miyamoto M., Maki T., Ichinokawa M., Kubota K.C., Shichinohe T., Hirano S., Ferrone S., Dosaka-Akita H., et al. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. Int. J. Oncol. 2012;40:965–974. doi: 10.3892/ijo.2011.1274. PubMed DOI PMC
Henle A.M., Nassar A., Puglisi-Knutson D., Youssef B., Knutson K.L. Downregulation of TAP1 and TAP2 in early stage breast cancer. PLoS ONE. 2017;12:e0187323. doi: 10.1371/journal.pone.0187323. PubMed DOI PMC
Ling A., Löfgren-Burström A., Larsson P., Li X., Wikberg M.L., Öberg Å., Stenling R., Edin S., Palmqvist R. TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. OncoImmunology. 2017;6:e1356143. doi: 10.1080/2162402X.2017.1356143. PubMed DOI PMC